As vaccine development becomes more and more competitive, companies are increasingly exploring delivery routes beyond the traditional needle and syringe. Inhaled vaccine and microneedle array patch platforms are two promising options. In this presentation, Head Kindeva SAB, John Patton, and Associate Director, Product and Process Development, Tim Peterson, share their insights on epithelial vaccine delivery.
Download your copy to discover:
- The current landscape of vaccine development
- Advantages of epithelial delivery
- An overview of particle engineering and spray drying technology to enhance stability of inhaled vaccines
- An introduction to intradermal vaccine delivery platforms and their benefits for mRNA delivery
Download the Presentation
Fields marked with an * are required.